Services on Demand
Journal
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista de nefrologia, dialisis y trasplante
On-line version ISSN 2346-8548
Abstract
ARIAS, Carlos et al. Glomerulonephritis due to minimal change disease post COVID-19 vaccine AstraZeneca. Rev. nefrol. dial. traspl. [online]. 2022, vol.42, n.1, pp.65-68. ISSN 2346-8548.
We report a case of a 28-year-old woman with minimal change disease secondary nephrotic syndrome 48 hours after the administration of the AstraZeneca SARS-CoV2 vaccine. The patient had suffered idiopathic nephrotic syndrome in childhood treated empirically with corticosteroids and cyclosporine, in complete remission from the age of 9. Some reports suggest that glomerular disease might appear infrequently associated to some vaccines.
Keywords : coronavirus; severe acute respiratory syndrome; SARS-CoV-2; vaccination; minimal change nephrotic syndrome.